Funding round
Xeltis raises €20.5M growth round
Xeltis (Netherlands) has raised €20.5M in a growth round, announced on July 28, 2026. The company is Develops living vascular access implants for hemodialysis patients. The round was led by Horizon 3 Healthcare, with participation from European Innovation Council, Invest-NL, VI Partners, EQT Life Sciences, DaVita.
Xeltis raised €20.5M to advance its aXess vascular access solution toward FDA approval and US commercial launch, with European commercialization ongoing.
Company
Xeltis
Amount
€20.5M (~$23.3M)
Round
Growth
Sector
Medical devices, vascular implants
Country
Netherlands
Announced
July 28, 2026
Track every raise, every day
This deal appeared in The Daily Raise, July 28, 2026. Get the next edition in your inbox.
Just raised too?
Turn your funding news into guaranteed media coverage while the momentum lasts.